MAYOLY SPINDLER Committed to your health. Every day.
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
MAYOLY SPINDLER
Committed to your health.
Every day.
OUR AMBITION
Become an
international reference
in gastroenterology
and dermo-cosmetics
2
CONTENTS
OUR ASSETS OUR FIELDS OF OUR EMPLOYEES’
A French company EXPERTISE COMMITMENT
An independent company Pharmaceuticals Our values
An extensive global footprint Dermo-cosmetics A responsible company
Contract Development &
Manufacturing
PRESENTATION EXCLUSIVELY 3
25/06/2018
FOR OFFICIAL BODIES
OUR ASSETS
a French company
▪ Three manufacturing facilities near Paris, 1 in Chatou
(West of Paris) and 2 in Dammarie-les-Lys (East of Paris).
▪ Over 880 employees worldwide, including nearly 610 in
France.
▪ Turnover: €190 million in 2017.
▪ 70% of products sold are made in France.
▪ An economic player contributing to France’s status as one
of the world’s leading pharmaceuticals exporters*.
* Source: LEEM (French Pharmaceutical Companies Association)– Economic report, 2016 issue.
PRESENTATION EXCLUSIVELY 4
25/06/2018
FOR OFFICIAL BODIES
OUR ASSETS NET CONSOLIDATED TURNOVER
an independent company 2009-2017 (€ million)
200 190
▪ Founded in 1909: for more than a century, an 180
154 159 161
167 173
entrepreneurial adventure.
160 145
138
140 126
▪ Still an entirely family-owned company.
120
100
▪ Financial independence, a main performance driver.
80
60
▪ Uninterrupted growth laying the foundations for the 40
20
company’s long-term development. 0
2009 2010 2011 2012 2013 2014 2015 2016 2017
PRESENTATION EXCLUSIVELY 5
25/06/2018
FOR OFFICIAL BODIES
OUR ASSETS
an extensive global footprint
▪ Established worldwide in more than 70 countries generating
45% of overall turnover (vs France 55%)
▪ Dynamic subsidiaries: in Europe, Eastern Europe, Asia and
Latin America (32% of international turnover in 2017)
▪ Business partners committed for the long term
▪ A proactive development policy
▪ With the acquisition in 2016 of Kibion, a Swedish company
principally operating in Germany and the Middle East,
Subsidiaries
Mayoly Spindler has become one of the world leaders in the
detection and control of Helicobacter pylori infections. Distributors
PRESENTATION EXCLUSIVELY 6
25/06/2018
FOR OFFICIAL BODIES
OUR FIELDS OF
EXPERTISE
7
PHARMACEUTICALS
8
PHARMACEUTICALS BREAKDOWN OF TURNOVER
Our historical pillar of development BY BUSINESS SECTOR IN 2017
CDMO *
Dermo-cosmetics €13 million
€23 million
7%
▪ Pharmaceutical sector: 80% of overall turnover in 2017
13 %
▪ Gastroenterology: 70% of our pharmaceutical business.
▪ A portfolio of therapeutic solutions spanning speciality
care, primary care and self-medication.
80 %
▪ An investment in collaborative R&D in gastroenterology.
Pharmaceuticals
€154 million
* Contract Development & Manufacturing Organization
PRESENTATION EXCLUSIVELY 9
25/06/2018
FOR OFFICIAL BODIES
OUR GE THERAPEUTIC SOLUTIONS PORTFOLIO
Acid reflux
Biliary lithiasis
Biliary cirrhosis Travel sickness
Diagnostic tests
Gaz
Digestive and renal
elimination functions
Abdominal pains Crohn’s disease Heartburn
Pancreatic insufficiency
Cystic fibrosis Colonoscopy Constipation Probiotics / Gut flora
PRESENTATION EXCLUSIVELY 10
25/06/2018
FOR OFFICIAL BODIESDERMO-COSMETICS
11DERMOCOSMETICS BREAKDOWN OF TURNOVER
Topicrem, the science of hydration BY BUSINESS SECTOR IN 2017
▪ Ultra-Moisturizing Body Milk
is the n°1 body moisturizer in France*. Dermo cosmetics
€23 million CDMO *
▪ High-quality manufacturing standards recognized on an €13 million
international level.
7%
▪ All worldwide production of Topicrem is made in France 13 %
(Dammarie-Les-Lys).
▪ An international brand (50% of Topicrem sales generated
outside of France). 80 %
Pharmaceuticals
* France IMS data Décembre 2016.
€154 million
* Contract Development & Manufacturing Organization
PRESENTATION EXCLUSIVELY 12
25/06/2018
FOR OFFICIAL BODIESPRODUCTION &
CONTRACT
MANUFACTURING
13PRODUCTION & CONTRACT
MANUFACTURING BREAKDOWN OF TURNOVER
BY BUSINESS SECTOR IN 2017
Technical prowess and responsiveness
CDMO *
▪ An agile structure offering our customers a wide range of €13 million
possibilities that meet their requirements in pharmaceuticals, Dermo cosmetics
nutraceuticals and dermo-cosmetics €23 million 7%
▪ A diversified offer: softgel capsules, tablets, capsules,
syrups, creams… 13 %
▪ A softgel capsules expertise requiring a particular
technicality. 80 %
▪ They trust us:
Pharmaceuticals
€154 million
* Contract Development & Manufacturing Organization
PRESENTATION EXCLUSIVELY 14
25/06/2018
FOR OFFICIAL BODIESOUR EMPLOYEES’
COMMITMENT,
CENTRAL TO OUR
SUCCESS
15OUR VALUES
RESPONSIBILITY RESPECT PRAGMATISM
Our performance is the result of the talent of our employees who, every day, share ambitious projects
and a test for challenge.
Our corporate culture is reflected in the empowerment of our teams, the opportunity to take initiatives
and the pragmatism of each individual.
Mayoly Spindler is a company where respect goes hand-in-hand with growth,
fostering the well-being of everyone.
PRESENTATION EXCLUSIVELY 16
25/06/2018
FOR OFFICIAL BODIESA RESPONSIBLE COMPANY
▪ OUR MAYOLY, our corporate responsibility programme.
▪ Three priorities: workplace well-being, commitment to the
community and care for the environment.
▪ Projects designed and coordinated by employees,
working in the general interest.
PRESENTATION EXCLUSIVELY 17
25/06/2018
FOR OFFICIAL BODIESMAYOLY
SPINDLER
AT A GLANCE
18€190 million turnover 45%
of turnover generated
Pharmaceuticals: 80%
outside of France.
Dermo-cosmetics: 13%
Production: 7%
Over 880 3 production sites
employees worldwide, near Paris: 1 in Chatou
including 610 in France. and 2 in Dammarie-les-lys
19
Figures as at 31/12/2017.Committed to your health.
Every day.You can also read
